Your session is about to expire
← Back to Search
RD047-023 for Scars
Study Summary
This trial will compare a new medication to an existing one to see if the new one is just as effective in treating scars.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a raised scar that can be treated and checked.I have a history of diabetes.I have a history of collagen vascular disorders.I can follow the study's instructions and meet its requirements.I have a raised scar that can be treated and checked.I expect to need surgery or hospitalization during the study.I am not pregnant.
- Group 1: RD047-023
- Group 2: Predicate Device
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any available slots left for this research program?
"According to the information on clinicaltrials.gov, this particular medical trial is not presently enrolling patients. Initially published in August of 2012 and last updated in November of that same year, it does not appear there are any current vacancies for participants; however, 105 other trials currently have openings available."
Are there any specific qualifications for joining this analysis?
"In order to be considered for this experiment, individuals must display symptoms of hypertrophy and have an age between 18-65. A cap of 40 participants has been set in place by the clinical trial's organisers."
Is this research encompassing geriatric patients?
"This trial is exclusively for individuals aged 18 to 65. However, there are alternative medical trials available for minors and seniors with 15 and 84 studies respectively."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger